FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for Quetiapine fumarate by Macleods Pharmaceuticals Limited, enabling a generic version of the antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Quetiapine fumarate (Quetiapine fumarate)

Snippet

SUPPL AP for QUETIAPINE FUMARATE (QUETIAPINE FUMARATE)